Literature DB >> 11234584

[Xenon anesthesia: from myth to reality].

J Leclerc1, R Nieuviarts, B Tavernier, B Vallet, P Scherpereel.   

Abstract

OBJECTIVE: To analyze the current knowledge concerning xenon anaesthesia. DATA SOURCES: References were obtained from computerized bibliographic research (Medline), recent review articles, the library of the service and personal files. STUDY SELECTION: All categories of articles on this topic have been selected. DATA EXTRACTION: Articles have been analysed for history, biophysics, pharmacology, toxicity and environmental effects and using prospect. DATA SYNTHESIS: The noble gas xenon has anaesthetic properties that have been recognized 50 years ago. Xenon is receiving renewed interest because it has many characteristics of an ideal anaesthetic. In addition to its lack of effects on cardiovascular system, xenon has a low solubility enabling faster induction of and emergence from anaesthesia than with other inhalational agents. Nevertheless, at present, the cost and arety of xenon limit its widespread use in clinical practice. The developement of closed rebreathing system that allowed recycling of xenon and therefore reducing its waste has led to a recent interest in this gas. Reducing its cost will help xenon to find its place among anaesthetic agents. An European multicentric clinical trial under submission will contribute to the discussion of the opportunity for xenon introduction in anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11234584     DOI: 10.1016/s0750-7658(00)00327-0

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  2 in total

Review 1.  Anesthetic gases and global warming: Potentials, prevention and future of anesthesia.

Authors:  Hina Gadani; Arun Vyas
Journal:  Anesth Essays Res       Date:  2011 Jan-Jun

2.  Xenon: a solution for anesthesia in liver disease?

Authors:  Ali Dabbagh; Samira Rajaei
Journal:  Hepat Mon       Date:  2012-11-20       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.